Last updated 2026-09-06
- Went public on TASE (SOFW), May 2021
- Raised $43.2M Follow-on PO led by Barak Capital Underwriters, May 2021
- Raised $8.4M Series A led by XT Hi-Tech, Aug 2019
Total raised
$51.6M
Last: Public Offering 2021-05
Stage
Public
Founded
2015
Headcount
151
HQ
Yokne'am Illit, Israel
Sector
Medical Devices
About
Sofwave Medical is an Israeli aesthetic medicine company that develops and sells an ultrasound system for non-invasive dermatological aesthetic treatment. The company's proprietary Synchronous Ultrasound Parallel Beam (SUPERB™) technology is FDA-cleared to improve facial lines and wrinkles, lift the eyebrow, submental, and neck tissue, treat acne scars, improve skin laxity on the upper arms, and provide short-term improvement in the appearance of cellulite. Sofwave also offers Pure Impact™ technology for muscle toning. The company was established in 2015 in the Alon Medtech Ventures incubator in Yokneam, Israel. Sofwave Medical Ltd. is publicly traded on the Tel Aviv Stock Exchange (TASE: SOFW).
Funding history · 2 rounds · $51.6M total
3 events/rounds · $51.6M Total Funding: $8.4M in Private Equity, $93.2M in Public Equity
May 2021
★ Barak Capital Underwriters
Aug 2019
Headcount over time
151 employees (2026-09) · 1 point
Offices
Yokne'am Illit, Israel · HQ / main office
Show all offices (2 more)
- United States
- Tustin, United States
Q&A
- When did Sofwave Medical go public and on what exchange?
- Sofwave Medical completed its Initial Public Offering (IPO) in May 2021 on the TASE, raising $50,000,000 at a valuation of $192,000,000.
- What is Sofwave Medical's primary focus in the aesthetic medical solutions market?
- Sofwave Medical specializes in non-invasive aesthetic medical solutions to improve skin laxity, provide lifting effects, and enhance muscle toning, utilizing its proprietary Synchronous Ultrasound Parallel Beam Technology (SUPERB™).
- What is the Pure Impact add-on module and its purpose?
- The Pure Impact add-on module is the world’s first plyometric muscle activation and toning device, designed to emulate complex, compound full-body muscle movements, expanding Sofwave's product portfolio for increased treatment versatility and efficiency.
- What is the employee count for Sofwave Medical?
- Sofwave Medical has 51–200 employees.
- What is the significance of Sofwave Medical's Pure Impact in conjunction with GLP-1 weight loss drugs?
- Sofwave Plus Pure Impact is designed to complement GLP-1 weight loss drugs by preventing muscle loss, increasing tone, and decreasing overall laxity, providing a comprehensive solution for enhancing physical appearance and health.
- What is Sofwave Medical's current market capitalization?
- Sofwave Medical's market capitalization is $303,534,131.
- When was Sofwave Medical founded?
- Sofwave Medical was founded in October 2015.
Team · 15
Shimon Eckhouse
Founder · Co-Founder & Chairman
Ariel Sverdlik
Founder · Co-Founder & CTO
Genady Nahshon
Founder · Co-founder, COO & Site Manager
Louis Scafuri
CEO
Orly Zilberman
External Director
Sarit Soukari Ben Yohenan
External Director
Assaf Mansour
Director
Lisa Haimovitz
Independent Outside Director
George Clark
Independent Director
Miguel Pardos
Chief Commercial Officer
Lina Omari
Chief Digital Officer
Assaf Korner
Chief Financial Officer
James Bartholomeusz
Chief Innovation Officer
Ruthie Amir
Chief Medical Officer
Carmit Meirnovski
executives
Sectors & technology
Primary sector
Medical Devices
Technologies
Target customers
Highlights
1 PatentsVerified
Tags
clinicsmedical-technologieshealthcare-providersskin-carenon-invasivetreatmentsultrasoundmedical-devices
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | sofwave.com |
|---|---|
| linkedin.com/company/18755820 | |
| facebook.com/Sofwave/ | |
| YouTube | youtube.com/channel/UC3RyhVm1CRtmU0EscGI3FrA |
| instagram.com/sofwavemed/ | |
| Wikipedia | en.wikipedia.org/wiki/Sofwave_Medical |
| Wikidata | wikidata.org/wiki/Q110460022 |
Identifiers & details
| Legal name | Sofwave Medical Ltd. |
|---|---|
| Former names | ArchimedUS Medical |
| Founded | 2015 |
| Employees (exact) | 151 |
| Offices | United States; Tustin |
| Market cap | $303.5M |
| Status reason | Public on TASE on May, 2021 |
| Wikidata QID | Q110460022 |
Acquisitions & public offerings
| Type | Date | Exchange | Ticker | Amount |
|---|---|---|---|---|
| IPO | 2021-05 | TASE | SOFW | $50.0M |
Radar intelligence
Patents
| EPO | 12 |
|---|
Web history (Wayback)
| Domain | sofwave.com |
|---|
Wikidata
| QID | Q110460022 |
|---|
Certificate / subdomain footprint
| Subdomains | 60 |
|---|
Israeli Companies Registrar (רשם החברות / ICA)
| Registrar # (ח.פ.) | 515198158 |
|---|---|
| Status | פעילה |
| Corp type | ישראלית חברה ציבורית |
| Incorporated | 2015-01-27 |
| Purpose | לעסוק בכל עיסוק חוקי |
| Liability | מוגבלת |
| In violation (unfiled) | no |
| Last annual report | 2020 |
| Active charges / liens | 0 |
| Registry events | 0 |
| Registered address | העוצמה 1 יקנעם עילית |